Citi tells investors it’s time to sell Moderna after 600%-plus stock gains

Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.

Source:MarketWatch
Disclaimer:Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.